As of January 2025, Jiangsu Hengrui Medicine has a market cap of $40.51B. This makes Jiangsu Hengrui Medicine the world's 425th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $36.61B | -7.43% |
2023 | $39.55B | 17.39% |
2022 | $33.69B | -24.02% |
2021 | $44.34B | -45.40% |
2020 | $81.21B | 52.82% |
2019 | $53.14B | 99.10% |
2018 | $26.69B | -0.59% |
2017 | $26.85B | 81.93% |
2016 | $14.76B | 11.16% |
2015 | $13.28B | 70.37% |
2014 | $7.79B | 8.55% |
2013 | $7.18B | 38.80% |
2012 | $5.17B | 12.47% |
2011 | $4.60B | -25.86% |
2010 | $6.20B | 36.14% |
2009 | $4.56B | 63.59% |
2008 | $2.78B | -18.45% |
2007 | $3.42B | 128.37% |
2006 | $1.50B | 255.41% |
2005 | $420.78M | 18.28% |
2004 | $355.74M | 48.63% |
2003 | $239.34M | -16.44% |
2002 | $286.42M | -28.92% |
2001 | $402.95M | -26.92% |
2000 | $551.35M | - |